Novozymes A/S (OTCMKTS:NVZMY) Sets New 52-Week High - Should You Buy?

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) shares reached a new 52-week high during trading on Monday . The company traded as high as $72.77 and last traded at $71.74, with a volume of 82091 shares. The stock had previously closed at $70.69.

Novozymes A/S Trading Up 1.8%

The company has a market capitalization of $34.18 billion, a PE ratio of 46.19, a P/E/G ratio of 3.87 and a beta of 0.92. The firm has a 50 day simple moving average of $64.84 and a two-hundred day simple moving average of $60.13.

Novozymes A/S Increases Dividend

The company also recently declared a dividend, which was paid on Wednesday, April 23rd. Investors of record on Monday, April 7th were given a dividend of $0.3758 per share. This is a positive change from Novozymes A/S's previous dividend of $0.17. The ex-dividend date of this dividend was Monday, April 7th. Novozymes A/S's dividend payout ratio is currently 47.47%.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.